Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Gov't & Regulatory

State FDA (SFDA), Ministry of Science and Technology (MOST), Minsitry of Health (MOH) and other China government agency policies and regulations and how they impact the industry...

US Legislators Target WuXi Bio and BGI; Aim to Prevent Transfer of US Genomic Data

China Announces Plans to Facilitate Foreign Investments in its Biopharma Industry

EQRx Gives up on In-licensing Drugs from China for Lower Cost Therapies in the West

China Eases Rules for Hong Kong Biopharmas to List on Mainland Exchanges

CFIUS Approves Sino Biopharm’s Acquisition of F-Star after Nine Month Wait

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital